H
Hossein Baharvand
Researcher at University of Science and Culture
Publications - 487
Citations - 20462
Hossein Baharvand is an academic researcher from University of Science and Culture. The author has contributed to research in topics: Embryonic stem cell & Stem cell. The author has an hindex of 56, co-authored 454 publications receiving 15081 citations. Previous affiliations of Hossein Baharvand include Avicenna Research Institute & Royan Institute.
Papers
More filters
Journal ArticleDOI
Novel spliced variants of OCT4, OCT4C and OCT4C1, with distinct expression patterns and functions in pluripotent and tumor cell lines
Mahshid Malakootian,Mahshid Malakootian,Fatemeh Mirzadeh Azad,Parisa Naeli,Mohammad Pakzad,Youssef Fouani,Elham Taheri Bajgan,Hossein Baharvand,Hossein Baharvand,Seyed Javad Mowla +9 more
TL;DR: The data revisited the current view of OCT4 gene structure and regulation, and revealed its complex genomic features and expression regulation in stem and tumor cells.
Journal ArticleDOI
Prospective Isolation of ISL1+ Cardiac Progenitors from Human ESCs for Myocardial Infarction Therapy
Zaniar Ghazizadeh,Zaniar Ghazizadeh,Faranak Fattahi,Mehdi Mirzaei,Delger Bayersaikhan,Jaesuk Lee,Sehyun Chae,Daehee Hwang,Kyunghee Byun,Mehdi Sharifi Tabar,Sara Taleahmad,Shahab Mirshahvaladi,Parisa Shabani,Hananeh Fonoudi,Paul A. Haynes,Hossein Baharvand,Nasser Aghdami,Todd Evans,Bonghee Lee,Ghasem Hosseini Salekdeh,Ghasem Hosseini Salekdeh +20 more
TL;DR: This study establishes an efficient method for scalable purification of human ISL1+ cardiac precursor cells for therapeutic applications and identifies ALCAM (CD166) as a surface marker that enabled the isolation of ISl1+ progenitor cells.
Journal ArticleDOI
MicroRNA profiling reveals important functions of miR-125b and let-7a during human retinal pigment epithelial cell differentiation
Fatemeh Shahriari,Leila Satarian,Sharif Moradi,Ali Sharifi Zarchi,Stefan Günther,Aryan Kamal,Mehdi Totonchi,Seyed-Javad Mowla,Thomas Braun,Hossein Baharvand,Hossein Baharvand +10 more
TL;DR: Functional analyses indicated that two RPE-enriched miRNAs could promote RPE fate at the expense of neural fate during RPE differentiation, and mechanistic interrogations might shed light on a better understanding of RPE cell development and provide insights for the future application of these cells in regenerative medicine.
Journal ArticleDOI
Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity.
Reyhaneh Khoshchehreh,Reyhaneh Khoshchehreh,Mehdi Totonchi,Juan C. Ramirez,Raul Torres,Hossein Baharvand,Hossein Baharvand,Alexandra Aicher,Marzieh Ebrahimi,Marzieh Ebrahimi,Christopher Heeschen +10 more
TL;DR: It is demonstrated that reprogrammed primary PDAC cultures are functionally distinct from parental PDAC cells resulting in drastically reduced tumourigenicity in vitro and in vivo, supporting the notion that epigenetic modulators could be a suitable approach to improve the dismal outcome of patients with pancreatic cancer.
Journal ArticleDOI
COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133+ Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial.
Mohammad Hassan Naseri,Hoda Madani,Seyed Hossein Ahmadi Tafti,Maryam Moshkani Farahani,Davood Kazemi Saleh,Hossein Hosseinnejad,Saeid Hosseini,Sepideh Hekmat,Zargham Hossein Ahmadi,Majid Dehghani,Alireza Saadat,Soura Mardpour,Seyedeh Esmat Hosseini,Seyedeh Esmat Hosseini,Maryam Esmaeilzadeh,Hakimeh Sadeghian,Gholamreza Bahoush,Ali Bassi,Ahmad Amin,Roghayeh Fazeli,Yaser Sharafi,Leila Arab,Mansour Movahhed,Saeid Davaran,Narges Ramezanzadeh,Azam Kouhkan,Ali Hezavehei,Mehrnaz Namiri,F Kashfi,A. Akhlaghi,Fattah Sotoodehnejadnematalahi,Ahmad Vosough Dizaji,Hamid Gourabi,Naeema Syedi,Abdol Hosein Shahverdi,Hossein Baharvand,Nasser Aghdami +36 more
TL;DR: This article published in Cell J (Yakhteh), Vol 20, No 2, Jul-Sep 2018, on pages 267-277, four affiliations were changed based on authors request.